Filtyp
Professor Contact details Email: cecile [dot] brokelind [at] har [dot] lu [dot] se Phone: +46 46 222 33 67Organisation Department of Business Law Room number: EC2-359 Service point: 10 WebpageCécile Brokelinds profile in Lund University research portalOther affiliations Researcher Lund Tax Academy Publications Displaying of publications. Sorted by year, then title. Filter by type AllBookBook chapt
https://www.lusem.lu.se/cecile-brokelind - 2026-05-28
Microsoft Word - Mindfulness-sustainability framework.docx Global scale Sustainability Mindfulness Individual scale Collective/Plane‐ tary well‐being Interrelation with others/ equity Human‐nature connection Environmental behavior/ consumption Social activism/ action Subjective well‐ being Behavioral regulation Adaptive & flexible response capacity Activation of core values/ empowerment Phy
https://www.lucsus.lu.se/sites/lucsus.lu.se/files/mindfulness-sustainability_framework.pdf - 2026-05-29
DELAT BESLUTSFATTANDE I PSYKIATRISK VÅRD OCH STÖD C E N T R U M F Ö R E V I D E N S B A S E R A D E P S Y K O S O C I A L A I N S A T S E R F Ö R P E R S O N E R M E D P S Y K I S K A F U N K T I O N S N E D S Ä T T N I N G DELAT BESLUTSFATTANDE I PSYKIATRISK VÅRD OCH STÖD ÖVERSÄTTNING OCH VALIDERING AV TRE INSTRUMENT SOM MÄTER DELAT BESLUTFATTANDE Mars 15 2 Förord Under de senaste decennierna har
https://www.cepi.lu.se/sites/cepi.lu.se/files/delat_beslutsfattande.pdf - 2026-05-29
EAC2021_Landscape A sample delivery system for in-light aerosol studies at MAX IV Laboratory C. Preger1,2,3, N. Walsh2 , A. C. Eriksson1,3, A. Kivimäki2,4, M. Patanen4, N. Prisle5, and J. Rissler1,3,6 1Ergonomics and Aerosol Technology, 2MAX IV Laboratory , 3NanoLund - all at Lund University, Lund, SE-22100, Sweden 4Nano and Molecular Systems Research Unit, 5Center for Atmospheric Research - all
https://www.nano.lu.se/sites/nano.lu.se/files/2021-10/Preger_NanoLund2021_Preger.pdf - 2026-05-29
This review compares the methodology of published clinical studies investigating the extended-half-life (EHL) factor VIII (FVIII) products, rFVIIIFc (efmoroctocog alfa, Elocta®/Eloctate®), BAY 94-9027 (damoctocog alfa pegol, Jivi®), BAX 855 (rurioctocog alfa pegol, Adynovate®) and N8-GP (turoctocog alfa pegol, Esperoct®) including the phase 2/3 studies, A-LONG (NCT01181128), PROTECT VIII (NCT01580
Background: A unique feature of alveolar mast cells is their low high-affinity IgE receptor (FcεRI) expression. Recent discoveries in uncontrolled asthma suggest that the appearance of FcεRI-expressing alveolar mast cells may be a novel disease-specific feature of allergic asthma. This study investigates whether increased FcεRI-expressing alveolar mast cells are present in patients with mild aller
The compositions of alternative jet fuels can vary radically, and the consequences of these differences are a subject of ongoing investigation. Numerical combustion simulations are vital to this research and require chemical reaction mechanisms that efficiently and accurately capture the chemical pathways of combustion. Here, we present the recently developed Z79 collection of small pathway-centri
Protein ADP-ribosylation is a reversible post-translational modification that regulates important cellular functions. The identification of modified proteins has proven challenging and has mainly been achieved via enrichment methodologies. Random mutagenesis was used here to develop an engineered Af1521 ADP-ribose binding macro domain protein with 1000-fold increased affinity towards ADP-ribose. T
Regular prophylactic treatment with factor VIII (FVIII) and factor IX (FIX) concentrates in hemophilia A and B, respectively, is introduced in early infancy and has resulted in dramatic improvement of the conditions. Recombinant FVIII and FIX concentrates have been available for > 25 years and have been modified and refined through the years; however, unfortunately frequent intravenous administrat
We have characterized 2 distinct mechanisms through which infectious agents may promote platelet adhesion and thrombus formation in flowing blood, thus contributing to the progression of disease. In one case, the process initiates when the integrin alpha(IIb)beta(3) mediates platelet arrest onto immobilized bacterial constituents that have bound plasma fibrinogen. If blood contains antibodies agai
The comparative and combined effects of nitric oxide (NO) and higher alkanes on methane oxidation were examined by experimentation and kinetic modeling. Experiments were conducted using fuel-lean, lower-alkanes mixtures with NO (0-400 ppm v/v) in an atmospheric flow reactor at residence time of 2 s over the temperature range of 820-950 K. NO was found to greatly promote methane conversion, and its
The airflow field around air-intake related geometries has been investigated experimentally and numerically. The configuration of the experimental set-up is used to model a jet engine running near the ground. The experiments have been carried out using both PIV and LDA techniques in order to obtain the mean and fluctuating velocity field as well as the low speed frequencies related to the system o
EndoS from Streptococcus pyogenes efficiently hydrolyzes the functionally important and conserved N-linked glycan of IgG in human blood. Repeated i.v. administration of EndoS in rabbits completely hydrolyzes the glycans of the whole IgG pool, despite the generation of anti-EndoS antibodies. EndoS administration had no apparent effects on the health of the animals. EndoS hydrolysis of the IgG glyca
We have conducted a phenomenological study on students who will become officers (KB-elever) and our subject is leadership. Our first purpose was to determine their point of view in leadership and how the describe it on two occasions. One occasion before and one after a field-training course in survival techniques. We also wanted to see if the view on leadership was shared and if it had changed aft
Group B Streptococcus (GBS) is a leading cause of invasive bacterial infections in human newborns. A key GBS virulence factor is its capsular polysaccharide (CPS), displaying terminal sialic acid (Sia) residues which block deposition and activation of complement on the bacterial surface. We recently demonstrated that GBS Sia can bind human CD33-related Sia-recognizing immunoglobulin (Ig) superfami
